Neurological polymorphism of systemic lupus erythematosus

Neurological polymorphism of systemic lupus erythematosus

Relevance. Damage to the nervous system during the progression of systemic lupus erythematosus (SLE) is not only one of the most common phenomena, but also an unfavorable prognostic criterion for the patient. At the moment, more than 19 types of neurolupus manifestations are known in both adult pati...

Full description

Bibliographic Details
Main Authors:	A. A. Garmanova, A. M. Morozov, Yu. E. Minakova, M. A. Belyak
Format:	Article
Language:	Russian
Published:	Private institution educational organization of higher education "Medical University "ReaViz" 2022-03-01
Series:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:	системная красная волчанка нейролюпус инсульт антифосфолипидный синдром головная боль аутоантитела когнитивные нарушения
Online Access:	https://vestnik.reaviz.ru/jour/article/view/370

Similar Items

ISCHEMIC STROKE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: P. S. Nikitenko, et al.
Published: (2019-07-01)

ANTI-CD20 MONOCLONAL ANTIBODIES IN TREATMENT OF HAEMOLYTIC ANEMIA IN A TEENAGE GIRL WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: R. V. Denisova, et al.
Published: (2012-11-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

Clinical significance of laboratory errors in patients with systemic lupus erythematosus
by: N.G. Klyukvina
Published: (2014-05-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

A case of primary antiphospholipid syndrome under the mask of systemic lupus erythematosus
by: N. S. Pozhilenko, et al.
Published: (2022-03-01)

КЛИНИЧЕСКИЙ СЛУЧАЙ ДЕБЮТА СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКИ ПОСЛЕ ПЕРЕНЕСЕННОЙ ИНФЕКЦИИ COVID-19
by: Светлана Вениаминовна Реева, et al.
Published: (2022-11-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Clinical and laboratory relationships in patients with different variants of the course of systemic lupus erythematosus
by: V. A. Lila
Published: (2020-03-01)

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N V Seredavkina, et al.
Published: (2009-12-01)

Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features
by: A. A. Shumilova, et al.
Published: (2022-08-01)

SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 1
by: Ekaterina I. Alexeeva, et al.
Published: (2018-04-01)

Systemic lupus erythematosus: Specific features of its course and therapy options
by: Aleksandr Mikhailovich Lila, et al.
Published: (2015-09-01)

Specific features of systemic lupus erythematosus in males: case reports and literature data
by: Natalia Gennadyevna Klyukvina, et al.
Published: (2013-12-01)

Severe lung involvement in a female patient with undiagnosed systemic lupus erythematosus
by: T. N. Gavva, et al.
Published: (2018-12-01)

LONG-TERM TREATMENT BY CYCLOSPORINE A OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: S. V. Slteksliina, et al.
Published: (2002-04-01)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01)

Skin lesions in systemic lupus erythematosus. Part 1: classification, etiology, pathogenesis
by: A. A. Shumilova, et al.
Published: (2022-06-01)

The specific features of cerebrovascular disease in systemic lupus erythematosus
by: D L Faizulina, et al.
Published: (2012-06-01)

ANTIMALARIAL DRUGS IN THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS: PAST, PRESENT, FUTURE
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2010-06-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Нейропсихические нарушения при ювенильном дебюте системной красной волчанки: результаты ретроспективного исследования
Published: (2018-06-01)

Systemic Lupus Erythematosus with neuropsychiatric manifestations in a child: case report and review of the international recommendations for the diagnostics and management
by: E. M. Кuchinskaya, et al.
Published: (2021-03-01)

Forecasting index of unfavorable outcomes of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2021-06-01)

USE OF MYCOPHENOLATE MOPHETYL IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: S.I. Valiyeva,, et al.
Published: (2006-03-01)

Concurrence of systemic lupus erythematosus and psoriatic arthritis: literature data and a case report
by: E. M. Agafonova, et al.
Published: (2018-12-01)

Systemic lupus erythematosus and vitamin D
by: N. G. Klyukvina
Published: (2015-06-01)

Experience with type I interferon inhibitor in systemic lupus erythematosus
by: Ya. A. Leineman, et al.
Published: (2022-08-01)

Specific features of regulatory T cells in patients with systemic lupus erythematosus
by: A. V. Torgashina, et al.
Published: (2018-12-01)

Anti-Mullerian hormone in systemic lupus erythematosus
by: Z. S. Alekberova, et al.
Published: (2021-02-01)

DIFFICULTIES OF DIAGNOSTICS OF «COMPETITIVE» PROCESSES: THE SYSTEMIC LUPUS ERYTHEMATOSUS AT THE PATIENT WITH THE MODERN COMORBIDITY. THE CLINICAL CASE
by: D. Y. Kostenko, et al.
Published: (2018-06-01)

The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort
by: E. A. Aseeva, et al.
Published: (2020-11-01)

Late-onset systemic lupus erythematosus in the elderly
by: N. G. Klyukvina
Published: (2018-01-01)

Efficiency of tocilizumab therapy for an exacerbation of systemic lupus erythematosus: A case report and a review of literature
by: S. K. Solovyev, et al.
Published: (2017-09-01)

Intravenous iloprost in the combination therapy of vascular disorders in patients with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2013-06-01)

Clinical significance of leptin in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2021-12-01)

ACUTE RESPIRATORY DISEASE AS THE DEBUT OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. Yu. Ischenko, et al.
Published: (2015-12-01)

Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)

The current status of the problem with systemic lupus erythematosus in Kazakhstan
by: B. G. Isayeva, et al.
Published: (2020-03-01)

SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 2
by: Ekaterina I. Alexeeva, et al.
Published: (2018-05-01)